Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| KIT | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 1.11E5 | Evidence |
|
||||
| KIT | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 9.66E4 | Evidence |
|
||||
| KIT | CRKL | CRKL: Crk-like protein | 8.90E4 | Evidence |
O
|
||||
| KIT | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 4.90E4 | Evidence |
|
||||
| KIT | NCK2 | NCK2: Cytoplasmic protein NCK2 | 3.76E4 | Evidence | |||||
| KIT | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 2.92E4 | Evidence | |||||
| KIT | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 2.57E4 | Evidence | |||||
| KIT | GRAP | GRAP: GRB2-related adapter protein | 1.40E4 | Evidence |
O
|
||||
| KIT | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 1.07E4 | Evidence | |||||
| KIT | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 1.07E4 | Evidence | |||||
| KIT | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 6.36E3 | Evidence | |||||
| KIT | JUP | JUP, CTNNG, DP3: Junction plakoglobin | 3.62E3 | Evidence | |||||
| KIT | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 477.0 | Evidence | |||||
| KIT | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 224.0 | Evidence | |||||
| KIT | LNK | SH2B3, LNK: SH2B adapter protein 3 | 224.0 | Evidence |
|
||||
| KIT | SYK | SYK: Tyrosine-protein kinase SYK | 206.0 | Evidence | |||||
| KIT | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 206.0 | Evidence | |||||
| KIT | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 206.0 | Evidence |
|
||||
| KIT | STAT3 | 200.0 | Evidence | ||||||
| KIT | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 185.0 | Evidence |
O
|
||||
| KIT | JAK1 | 167.0 | Evidence | ||||||
| KIT | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 167.0 | Evidence |
|
||||
| KIT | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 167.0 | Evidence | |||||
| KIT | CSK | CSK: Tyrosine-protein kinase CSK | 149.0 | Evidence | |||||
| KIT | VAV1 | VAV1, VAV: Proto-oncogene vav | 149.0 | Evidence | |||||
| KIT | BMX | N/A | 149.0 | Evidence | |||||
| KIT | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 147.0 | Evidence | |||||
| KIT | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 147.0 | Evidence |
|
||||
| KIT | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 147.0 | Evidence | |||||
| KIT | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 147.0 | Evidence | |||||
| KIT | GRB10 | N/A | 141.0 | Evidence |
|
||||
| KIT | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 135.0 | Evidence |
|
||||
| KIT | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 132.0 | Evidence |
O
|
||||
| KIT | APS | SH2B2, APS: SH2B adapter protein 2 | 132.0 | Evidence |
|
||||
| KIT | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 132.0 | Evidence | |||||
| KIT | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 132.0 | Evidence | |||||
| KIT | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 125.0 | Evidence |
|
||||
| KIT | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 121.0 | Evidence |
|
||||
| KIT | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 119.0 | Evidence |
O
|
||||
| KIT | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 110.0 | Evidence |
|
||||
| KIT | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 92.10 | Evidence | |||||
| KIT | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 89.20 | Evidence |
|
||||
| KIT | CRK | CRK: Proto-oncogene C-crk | 85.60 | Evidence |
|
||||
| KIT | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 82.50 | Evidence |
|
||||
| KIT | LYN | LYN: Tyrosine-protein kinase Lyn | 80.00 | Evidence |
|
||||
| KIT | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 72.70 | Evidence |
|
||||
| KIT | HCK | N/A | 52.50 | Evidence |
|
||||
| KIT | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 39.10 | Evidence | |||||
| KIT | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 37.80 | Evidence | |||||
| KIT | ADAM15 | ADAM15, MDC15: ADAM 15 precursor | 37.80 | Evidence | |||||
| KIT | TRPV4 | TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb | 37.80 | Evidence | |||||
| KIT | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 37.80 | Evidence | |||||
| KIT | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 37.80 | Evidence | |||||
| KIT | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 37.80 | Evidence | |||||
| KIT | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 37.40 | Evidence | |||||
| KIT | NCAM1 | NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor | 34.80 | Evidence | |||||
| KIT | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 34.80 | Evidence |
|
||||
| KIT | EPOR | EPOR: Erythropoietin receptor precursor | 34.80 | Evidence |
|
||||
| KIT | CNTN1 | CNTN1: Contactin-1 precursor | 33.90 | Evidence | |||||
| KIT | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 33.90 | Evidence | |||||
| KIT | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 33.90 | Evidence | |||||
| KIT | EPHA8 | EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor | 33.90 | Evidence | |||||
| KIT | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 33.90 | Evidence | |||||
| KIT | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 33.90 | Evidence | |||||
| KIT | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 32.70 | Evidence | |||||
| KIT | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 32.70 | Evidence |
O
|
||||
| KIT | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 30.30 | Evidence | |||||
| KIT | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 28.20 | Evidence | |||||
| KIT | THY1 | THY1: Thy-1 membrane glycoprotein precursor | 28.20 | Evidence | |||||
| KIT | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 28.20 | Evidence | |||||
| KIT | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 28.20 | Evidence | |||||
| KIT | FIGF | FIGF, VEGFD: Vascular endothelial growth factor D precursor | 26.70 | Evidence | |||||
| KIT | EPS15 | EPS15, AF1P: Epidermal growth factor receptor substrate 15 | 25.70 | Evidence | |||||
| KIT | INSR | INSR: Insulin receptor precursor | 25.3 | Evidence | |||||
| KIT | EPHA4 | EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor | 25.3 | Evidence | |||||
| KIT | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 25.3 | Evidence | |||||
| KIT | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 25.20 | Evidence | |||||
| KIT | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 25.00 | Evidence | |||||
| KIT | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 24.90 | Evidence | |||||
| KIT | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 24.90 | Evidence | |||||
| KIT | GHR | GHR: Growth hormone receptor precursor | 24.80 | Evidence | |||||
| KIT | ITGB4 | N/A | 24.80 | Evidence | |||||
| KIT | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 24.80 | Evidence | |||||
| KIT | CD4 | CD4: T-cell surface glycoprotein CD4 precursor | 24.80 | Evidence | |||||
| KIT | MAG | MAG, GMA: Myelin-associated glycoprotein precursor | 24.80 | Evidence | |||||
| KIT | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 24.80 | Evidence | |||||
| KIT | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 22.90 | Evidence | |||||
| KIT | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 22.90 | Evidence | |||||
| KIT | SLAMF1 | SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor | 22.40 | Evidence | |||||
| KIT | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 22.30 | Evidence | |||||
| KIT | ACTN4 | ACTN4: Alpha-actinin-4 | 22.30 | Evidence | |||||
| KIT | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 22.30 | Evidence | |||||
| KIT | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 22.30 | Evidence | |||||
| KIT | ROBO1 | ROBO1, DUTT1: Roundabout homolog 1 precursor | 22.20 | Evidence | |||||
| KIT | IQGAP2 | IQGAP2: Ras GTPase-activating-like protein IQGAP2 | 21.40 | Evidence | |||||
| KIT | SOS1 | SOS1: Son of sevenless homolog 1 | 21.40 | Evidence | |||||
| KIT | DOK1 | DOK1: Docking protein 1 | 20.50 | Evidence |
|
||||
| KIT | CD2AP | CD2AP: CD2-associated protein | 20.50 | Evidence | |||||
| KIT | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 20.00 | Evidence | |||||
| KIT | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 19.70 | Evidence | |||||
| KIT | PLAUR | PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor | 19.10 | Evidence | |||||
| KIT | GAB1 | GAB1: GRB2-associated-binding protein 1 | 18.60 | Evidence | |||||
| KIT | IRS1 | IRS1: Insulin receptor substrate 1 | 18.60 | Evidence | |||||
| KIT | S100B | S100B: Protein S100-B | 18.60 | Evidence | |||||
| KIT | CNN3 | CNN3: Calponin-3 | 18.60 | Evidence | |||||
| KIT | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 17.10 | Evidence | |||||
| KIT | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 17.10 | Evidence | |||||
| KIT | ATP2A2 | ATP2A2, ATP2B: Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 17.10 | Evidence | |||||
| KIT | SH3BP5 | N/A | 16.60 | Evidence | |||||
| KIT | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 16.60 | Evidence | |||||
| KIT | PLD2 | PLD2: Phospholipase D2 | 16.60 | Evidence | |||||
| KIT | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 16.60 | Evidence | |||||
| KIT | CSH2 | GH1: Somatotropin precursor | 16.40 | Evidence | |||||
| KIT | SPTA1 | SPTA1, SPTA: Spectrin alpha chain, erythrocyte | 16.40 | Evidence | |||||
| KIT | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 16.40 | Evidence | |||||
| KIT | S100A3 | S100A3, S100E: Protein S100-A3 | 16.40 | Evidence | |||||
| KIT | K-ALPHA-1 | TUBA1B: Tubulin alpha-1B chain | 16.20 | Evidence | |||||
| KIT | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 15.60 | Evidence | |||||
| KIT | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 15.30 | Evidence | |||||
| KIT | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 15.00 | Evidence | |||||
| KIT | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 15.00 | Evidence | |||||
| KIT | DAB1 | DAB1: Disabled homolog 1 | 14.60 | Evidence | |||||
| KIT | MYL4 | MYL4, MLC1, PRO1957: Myosin light polypeptide 4 | 14.60 | Evidence | |||||
| KIT | H2-ALPHA | TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain | 14.10 | Evidence | |||||
| KIT | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 13.50 | Evidence | |||||
| KIT | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 13.2 | Evidence | |||||
| KIT | CD44 | N/A | 12.50 | Evidence | |||||
| KIT | SNX2 | SNX2, TRG9: Sorting nexin-2 | 11.70 | Evidence | |||||
| KIT | NULL | Ig lambda chain V-II region NEI | 11.70 | Evidence | |||||
| KIT | HLA-A | HLA-A, HLAA: HLA class I histocompatibility antigen, A-68 alpha chain precursor | 11.70 | Evidence | |||||
| KIT | EVL | EVL, RNB6: Ena/VASP-like protein | 11.70 | Evidence | |||||
| KIT | CEBPA | CEBPA: CCAAT/enhancer-binding protein alpha | 11.70 | Evidence | |||||
| KIT | CTPS | CTPS: CTP synthase 1 | 11.60 | Evidence | |||||
| KIT | CCR5 | CCR5: CCR5 receptor (Fragment) | 11.30 | Evidence | |||||
| KIT | MS4A1 | MS4A1, CD20: B-lymphocyte antigen CD20 | 11.30 | Evidence | |||||
| KIT | FASLG | FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 | 11.30 | Evidence | |||||
| KIT | CD5 | CD5, LEU1: T-cell surface glycoprotein CD5 precursor | 11.30 | Evidence | |||||
| KIT | CD36 | CD36, GP3B, GP4: Platelet glycoprotein 4 | 11.20 | Evidence | |||||
| KIT | SHC2 | N/A | 10.70 | Evidence | |||||
| KIT | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 10.50 | Evidence | |||||
| KIT | FLT4 | VEGFR3 long form | 10.50 | Evidence | |||||
| KIT | PPP1R14A | PPP1R14A, CPI17, PPP1INL: Protein phosphatase 1 regulatory subunit 14A | 10.50 | Evidence | |||||
| KIT | WEE1 | WEE1: Wee1-like protein kinase | 10.30 | Evidence | |||||
| KIT | GNAI1 | GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit | 9.60 | Evidence | |||||
| KIT | GNAI3 | GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha | 9.60 | Evidence | |||||
| KIT | CDK5 | CDK5: Cell division protein kinase 5 | 9.29 | Evidence | |||||
| KIT | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 9.29 | Evidence | |||||
| KIT | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 9.29 | Evidence | |||||
| KIT | RPS6KB1 | N/A | 9.29 | Evidence | |||||
| KIT | NMT1 | NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 | 9.29 | Evidence | |||||
| KIT | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 9.29 | Evidence | |||||
| KIT | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 9.27 | Evidence | |||||
| KIT | STAM2 | STAM2: Signal transducing adapter molecule 2 | 8.90 | Evidence | |||||
| KIT | EPHA2 | EPHA2, ECK: Ephrin type-A receptor 2 precursor | 8.86 | Evidence | |||||
| KIT | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 8.86 | Evidence | |||||
| KIT | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 8.78 | Evidence | |||||
| KIT | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 8.40 | Evidence | |||||
| KIT | GNA11 | GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 | 7.78 | Evidence | |||||
| KIT | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 7.74 | Evidence | |||||
| KIT | CNN1 | CNN1: Calponin-1 | 7.74 | Evidence | |||||
| KIT | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 7.61 | Evidence | |||||
| KIT | GMFB | GMFB: Glia maturation factor beta | 7.55 | Evidence | |||||
| KIT | LOC649805 | Ig heavy chain V-II region COR | 7.14 | Evidence | |||||
| KIT | ETS2 | ETS2: Protein C-ets-2 | 7.12 | Evidence | |||||
| KIT | TOM1L1 | TOM1L1, SRCASM: TOM1-like protein 1 | 7.11 | Evidence | |||||
| KIT | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 7.05 | Evidence | |||||
| KIT | CAV1 | CAV1, CAV: Caveolin-1 | 6.93 | Evidence | |||||
| KIT | MOS | MOS: Proto-oncogene serine/threonine-protein kinase mos | 6.67 | Evidence | |||||
| KIT | WASPIP | N/A | 6.63 | Evidence | |||||
| KIT | CTTN | CTTN, EMS1: Src substrate cortactin | 6.52 | Evidence | |||||
| KIT | CGA | CGA: Glycoprotein hormones alpha chain precursor | 6.52 | Evidence | |||||
| KIT | CDC2 | CDC2: Cell division control protein 2 homolog | 6.11 | Evidence | |||||
| KIT | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 5.97 | Evidence | |||||
| KIT | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 5.84 | Evidence | |||||
| KIT | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 5.63 | Evidence | |||||
| KIT | STYK1 | STYK1, NOK: Tyrosine protein-kinase STYK1 | 5.62 | Evidence | |||||
| KIT | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 5.26 | Evidence | |||||
| KIT | TIMP2 | TIMP2: Metalloproteinase inhibitor 2 precursor | 5.14 | Evidence | |||||
| KIT | RASGRF2 | RASGRF2: Ras protein-specific guanine nucleotide-releasing factor 2 (Fragment) | 4.80 | Evidence | |||||
| KIT | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 4.80 | Evidence | |||||
| KIT | ASB6 | ASB6: Ankyrin repeat and SOCS box protein 6 | 4.80 | Evidence | |||||
| KIT | SRA1 | APBB3, FE65L2: Amyloid beta A4 precursor protein-binding family B member 3 | 4.80 | Evidence | |||||
| KIT | KCNJ3 | KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 | 4.77 | Evidence | |||||
| KIT | CTNNB1 | CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 | 4.56 | Evidence | |||||
| KIT | DYRK3 | N/A | 4.56 | Evidence | |||||
| KIT | IL10RB | IL10RB, CRFB4, D21S58, D21S66: Interleukin-10 receptor beta chain precursor | 4.56 | Evidence | |||||
| KIT | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 4.56 | Evidence | |||||
| KIT | PTPN11 | N/A | 4.46 | Evidence |
|
||||
| KIT | CTDP1 | CTDP1, FCP1: RNA polymerase II subunit A C-terminal domain phosphatase | 4.31 | Evidence | |||||
| KIT | TGFBR1 | TGFBR1: TGF-beta receptor type-1 precursor | 4.03 | Evidence | |||||
| KIT | MYO3A | MYO3A: Myosin IIIA | 4.02 | Evidence | |||||
| KIT | IL2RG | IL2RG: Cytokine receptor common gamma chain precursor | 4.01 | Evidence | |||||
| KIT | FES | Proto-oncogene c-fes variant 3 | 3.99 | Evidence | |||||
| KIT | RASA4 | RASA4, CAPRI, GAPL, KIAA0538: Ras GTPase-activating protein 4 | 3.96 | Evidence | |||||
| KIT | FGFR2 | N/A | 3.70 | Evidence | |||||
| KIT | SCAP2 | SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 | 3.58 | Evidence | |||||
| KIT | SASH1 | SASH1, KIAA0790, PEPE1: SAM and SH3 domain-containing protein 1 | 3.58 | Evidence | |||||
| KIT | RICS | RICS: Rac GTPase activating protein | 3.58 | Evidence | |||||
| KIT | DOK4 | DOK4: Docking protein 4 | 3.58 | Evidence | |||||
| KIT | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 3.46 | Evidence | |||||
| KIT | MTHFD1 | MTHFD1, MTHFC, MTHFD: C-1-tetrahydrofolate synthase, cytoplasmic | 3.39 | Evidence | |||||
| KIT | RPS3 | RPS3, OK/SW-cl.26: 40S ribosomal protein S3 | 3.39 | Evidence | |||||
| KIT | DPF2 | DPF2, REQ, UBID4: Zinc finger protein ubi-d4 | 3.39 | Evidence | |||||
| KIT | HNRPK | N/A | 3.39 | Evidence | |||||
| KIT | SNX15 | SNX15: Sorting nexin-15 | 3.15 | Evidence | |||||
| KIT | CHUK | N/A | 3.02 | Evidence | |||||
| KIT | ABCF1 | N/A | 3.02 | Evidence | |||||
| KIT | BRCA2 | BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein | 3.02 | Evidence | |||||
| KIT | USP10 | USP10, KIAA0190: Ubiquitin carboxyl-terminal hydrolase 10 | 3.02 | Evidence | |||||
| KIT | RP2 | RP2: Protein XRP2 | 2.70 | Evidence | |||||
| KIT | PPP2CA | PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | 2.70 | Evidence | |||||
| KIT | CTNND2 | CTNND2, NPRAP: Catenin delta-2 | 2.70 | Evidence | |||||
| KIT | USP47 | USP47: Ubiquitin carboxyl-terminal hydrolase 47 | 2.70 | Evidence | |||||
| KIT | COPA | COPA: Coatomer subunit alpha | 2.70 | Evidence | |||||
| KIT | RARS | RARS: Arginyl-tRNA synthetase, cytoplasmic | 2.70 | Evidence | |||||
| KIT | VCPIP1 | VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 | 2.44 | Evidence | |||||
| KIT | NFKBIA | NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha | 2.44 | Evidence | |||||
| KIT | STIP1 | STIP1: Stress-induced-phosphoprotein 1 | 2.44 | Evidence | |||||
| KIT | HLA-DQB1 | HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre | 2.43 | Evidence | |||||
| KIT | GNA12 | GNA12: Guanine nucleotide-binding protein alpha-12 subunit | 2.23 | Evidence | |||||
| KIT | MUSK | MUSK: Muscle, skeletal receptor tyrosine protein kinase precursor | 2.19 | Evidence | |||||
| KIT | CRK | N/A | 2.19 | Evidence |
|
||||
| KIT | CASP8 | N/A | 2.15 | Evidence | |||||
| KIT | ANXA6 | ANXA6, ANX6: Annexin A6 | 2.12 | Evidence | |||||
| KIT | GRIN2A | GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor | 2.11 | Evidence | |||||
| KIT | HLA-F | HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec | 2.09 | Evidence | |||||
| KIT | CASP3 | CASP3, CPP32: Caspase-3 precursor | 2.05 | Evidence | |||||
| KIT | PPP1R12A | PPP1R12A, MBS, MYPT1: Protein phosphatase 1 regulatory subunit 12A | 2.05 | Evidence | |||||
| KIT | EVL | N/A | 1.93 | Evidence | |||||
| KIT | SHC1 | SHC1, RP11-307C12.1-001, hCG_1997126: SHC | 1.93 | Evidence | |||||
| KIT | GRIN2B | GRIN2B, NMDAR2B: Glutamate [NMDA] receptor subunit epsilon-2 precursor | 1.90 | Evidence | |||||
| KIT | SOS2 | SOS2: Son of sevenless homolog 2 | 1.81 | Evidence | |||||
| KIT | MAP4K5 | MAP4K5: Mitogen-activated protein kinase kinase kinase kinase 5 | 1.61 | Evidence | |||||
| KIT | CRIP2 | CRIP2, CRP2: Cysteine-rich protein 2 | 1.48 | Evidence | |||||
| KIT | MAPK7 | mitogen-activated protein kinase 7 isoform 1 | 1.48 | Evidence | |||||
| KIT | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 1.41 | Evidence | |||||
| KIT | NMI | NMI: N-myc-interactor | 1.36 | Evidence | |||||
| KIT | GNA14 | GNA14: Guanine nucleotide-binding protein alpha-14 subunit | 1.36 | Evidence | |||||
| KIT | BCR | N/A | 1.30 | Evidence | |||||
| KIT | ANKK1 | ANKK1, PKK2, SGK288: Ankyrin repeat and protein kinase domain-containing protein | 1.18 | Evidence | |||||